Patriot Investment Management Inc. Ocugen, Inc. Transaction History

Patriot Investment Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$6.36 - $8.51 $100,640 - $134,662	-15,824 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$5.52 - $15.68 $87,447 - $248,402	-15,842 Reduced 50.03%	15,824 $127,000
Q1 2021 Apr 29, 2021	BUY	$1.66 - $15.81 $52,565 - $500,639	31,666 New	31,666 $215,000
Q4 2020 Feb 09, 2021	SELL	$0.28 - $2.6 $5,600 - $52,000	-20,000 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$0.2 - $0.72 $4,000 - $14,400	20,000 New	20,000 $6,000

123

68.6M

478K

253K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $147M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Patriot Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Patriot Investment Management Inc. with notifications on news.